← DEXCOM INC DXCM
Market Price
$89.80
Market Cap
$35.31B
P/E Ratio
42.97
Revenue (FY 2025)
↑15.6% YoY
$4.66B
3-Yr CAGR: 17.0%
Net Income
↑45.1% YoY
$836.30M
Net Margin: 17.9%
Free Cash Flow
↑70.8% YoY
$1.08B
FCF Yield: 3.05%
EPS (Diluted)
↑47.2% YoY
$2.09
Basic: $2.14
Return on Equity
Efficiency
30.5%
ROA: 441.6%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (DXCM)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $573.3M | — | $378.4M | $-65.6M | — | — | — | $56.2M | $0.5M | — |
| FY 2017 | $718.5M | +25.3% | $492.1M | $-50.2M | +23.5% | — | — | $92.0M | $26.0M | +5,100.0% |
| FY 2018 | $1,031.6M | +43.6% | $663.9M | $-127.1M | -153.2% | — | — | $123.2M | $56.1M | +115.8% |
| FY 2019 | $1,476.0M | +43.1% | $931.5M | $101.1M | +179.5% | $0.28 | — | $314.5M | $134.5M | +139.8% |
| FY 2020 | $1,926.7M | +30.5% | $1,280.1M | $493.6M | +388.2% | $1.26 | +360.0% | $475.6M | $276.6M | +105.7% |
| FY 2021 | $2,448.5M | +27.1% | $1,680.5M | $154.7M | -68.7% | $0.39 | -69.4% | $442.5M | $53.3M | -80.7% |
| FY 2022 | $2,909.8M | +18.8% | $1,883.1M | $341.2M | +120.6% | $0.82 | +111.6% | $669.5M | $304.7M | +471.7% |
| FY 2023 | $3,622.3M | +24.5% | $2,288.9M | $541.5M | +58.7% | $1.30 | +58.5% | $748.5M | $511.9M | +68.0% |
| FY 2024 | $4,033.0M | +11.3% | $2,438.2M | $576.2M | +6.4% | $1.42 | +9.2% | $989.5M | $630.7M | +23.2% |
| FY 2025 | $4,662.0M | +15.6% | $2,801.9M | $836.3M | +45.1% | $2.09 | +47.2% | $1,440.7M | $1,077.2M | +70.8% |
Valuation
Market Price
$89.80
Market Cap
$35.31B
Enterprise Value
N/A
P/E Ratio
42.97
P/B Ratio
12.62
FCF Yield
3.05%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
60.10%
Operating Margin
19.56%
Net Margin
17.94%
Return on Equity (ROE)
30.46%
Return on Assets (ROA)
441.55%
Asset Turnover
24.61x
Revenue 3-Yr CAGR
17.01%
Financial Health & Liquidity
Current Ratio
0.09
Cash Ratio
0.43
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$917.70M
Total Debt
N/A
Book Value / Share
$7.12
Cash Flow Efficiency
Operating Cash Flow
$1.44B
Capital Expenditures (CapEx)
$363.50M
Free Cash Flow
$1.08B
OCF / Revenue
30.90%
FCF / Revenue
23.11%
FCF 3-Yr CAGR
52.34%
Per Share Metrics
EPS (Diluted)
$2.09
EPS (Basic)
$2.14
Dividends / Share
N/A
Book Value / Share
$7.12
EPS YoY Growth
47.18%
Balance Sheet (FY 2025)
Total Assets
$189.40M
Total Liabilities
$2.14B
Stockholders' Equity
$2.75B
Current Assets
$189.40M
Current Liabilities
$2.14B